Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients (Q69253729)
Jump to navigation
Jump to search
scientific article published on 01 December 1989
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients |
scientific article published on 01 December 1989 |
Statements
Selegiline as an adjunct to conventional levodopa therapy in Parkinson's disease. Experience with this type B monoamine oxidase inhibitor in 200 patients (English)
T S Elizan
M D Yahr
D A Moros
M R Mendoza
S Pang
1 December 1989